Robbins Farley LLC Merck & Co., Inc. Transaction History

Robbins Farley LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $3,759 - $4,820	43 New	43 $4,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $69,834 - $78,280	-950 Reduced 95.0%	50 $4,000
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $18,070 - $22,635	-250 Reduced 20.0%	1,000 $77,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $89,600 - $98,537	1,250 New	1,250 $94,000
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $98,082 - $108,489	-1,395 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $96,059 - $113,148	1,395 New	1,395 $109,000

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

Stay updated on Robbins Farley LLC with notifications on news.